Zelira Therapeutics Limited (ZLDAF)
OTCMKTS · Delayed Price · Currency is USD
0.4165
0.00 (0.00%)
At close: Jan 30, 2026
Zelira Therapeutics Market Cap
Zelira Therapeutics has a market cap or net worth of $5.15 million as of February 12, 2026. Its market cap has increased by 15.87% in one year.
Market Cap
5.15M
Enterprise Value
6.78M
Revenue
430.00
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.42
Market Cap Chart
Since November 22, 2016, Zelira Therapeutics's market cap has decreased from 11.37M to 5.15M, a decrease of -54.73%. That is a compound annual growth rate of -8.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 5.15M | 51.92% |
| Dec 30, 2025 | 3.39M | -22.17% |
| Dec 31, 2024 | 4.35M | -37.46% |
| Dec 29, 2023 | 6.96M | 6.95% |
| Dec 30, 2022 | 6.51M | -78.83% |
| Dec 31, 2021 | 30.74M | -63.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BetterLife Pharma | 6.49M |
| Brainstorm Cell Therapeutics | 6.46M |
| GPL Holdings | 5.83M |
| Bioxytran | 5.56M |
| LakeShore Biopharma | 5.33M |
| Clearside Biomedical | 5.10M |
| AXIM Biotechnologies | 4.99M |
| Enzon Pharmaceuticals | 4.79M |